Search clinical trials for: Teclistamab
Total 27 results
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Netherlands, Spain, France, Sweden
-
Janssen-Cilag Ltd.RecruitingRelapsed/Refractory Multiple Myeloma (RRMM)France, Denmark, Israel, Spain, Italy, Germany, Sweden
-
Multiple Myeloma Research ConsortiumNot yet recruitingRefractory Multiple Myeloma | Relapse Multiple Myeloma
-
Janssen Research & Development, LLCNo longer available
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple Myeloma
-
Janssen Pharmaceutical K.K.Active, not recruitingHematologic MalignanciesJapan
-
Janssen Research & Development, LLCActive, not recruitingHematological MalignanciesCanada, United States, France, Italy, United Kingdom, Germany, Belgium, Netherlands, Spain, Sweden, China
-
SCRI Development Innovations, LLCJanssen Research & Development, LLCRecruiting
-
University Health Network, TorontoJanssen Inc.Not yet recruitingMultiple Myeloma | Relapsed Cancer | Refractory Cancer
-
Jack KhouriNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Cytokine Release Syndrome | Immune Effector Cell Associated Neurotoxicity SyndromeUnited States
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Korea, Republic of, Canada, Israel, Spain, Japan, Australia
-
Carl Ola Landgren, MD, PhDJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed/ Refractory Multiple MyelomaUnited States, Germany, Spain, France
-
European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaUnited Kingdom, Czechia, Australia, Austria, Belgium, Denmark, Germany, Greece, Italy, Netherlands, Norway, Serbia, Switzerland, Turkey, Brazil
-
University Hospital, LilleJanssen Pharmaceutica N.V., BelgiumNot yet recruiting
-
PETHEMA FoundationJanssen PharmaceuticaRecruitingHigh-Risk de Novo Multiple MyelomaSpain
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Germany, Netherlands, Spain
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Belgium, United Kingdom, France, Australia
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada, Australia, China, Germany, Belgium, Malaysia, Turkey, Japan, Israel, Sweden, Spain, United Kingdom, Czechia, Denmark, Brazil, Italy, France, Netherlands, Poland, Austria, Portugal, Greece, India
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Belgium, Korea, Republic of, United Kingdom, Sweden, Italy, Denmark, Japan, Taiwan, China, Germany, Spain, France, Netherlands, Turkey, Russian Federation, Poland, Greece, Argentina, Brazil
-
Irene Ghobrial, MDJanssen Research & Development, LLCRecruitingMultiple Myeloma | Smoldering Multiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Nantes University HospitalJanssen PharmaceuticaNot yet recruiting
-
University of Heidelberg Medical CenterJanssen Research & Development, LLC; Deutsche Studiengruppe Multiples Myelom...Recruiting
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaBelgium, Korea, Republic of, Australia, United Kingdom, France, Sweden, Spain, Turkey, Italy, Czechia, Netherlands, Poland, Switzerland, Germany
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Italy, Germany, France, Japan, Israel, Belgium, Denmark, Sweden, Canada, Spain, Czechia, Poland, Australia, Netherlands, United Kingdom, India, China
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States